|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 7
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 10
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain H
21–234(214 aa)
Chain J
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 12
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 11
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain J
21–234(214 aa)
Chain K
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 12
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 12
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain H
21–234(214 aa)
Chain I
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 15
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain I
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 8
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain J
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 5
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain K
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain H
21–234(214 aa)
Chain I
21–234(214 aa)
Chain J
21–234(214 aa)
Chain K
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 27
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain H
21–234(214 aa)
Chain I
21–234(214 aa)
Chain J
21–234(214 aa)
Chain K
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 27
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 7
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain H
21–234(214 aa)
Chain I
21–234(214 aa)
Chain J
21–234(214 aa)
Chain K
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 27
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 8
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain H
21–234(214 aa)
Chain I
21–234(214 aa)
Chain J
21–234(214 aa)
Chain K
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 27
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2AI0
Anti-Cocaine Antibody 7.5.21, Crystal Form III
Deposited 2005-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 9
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain I
21–234(214 aa)
Chain K
21–234(214 aa)
|
Not recorded
|
SO4 SULFATE ION × 15
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;16% PEG8000, 0.3M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.20 Å
R-free 0.279
|
|
2IPT
PFA1 Fab Fragment
Deposited 2006-10-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
123–234(112 aa)
|
Not recorded
|
ACM ACETAMIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;294 K;0.1 M Hepes, 25% PEG3350, pH 7.5, VAPOR DIFFUSION, temperature 294K
|
Resolution 2.00 Å
R-free 0.223
|
|
4KVC
2H2 Fab fragment of immature Dengue virus
Deposited 2013-05-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
120–230(111 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;25% PEG 6000
0.1 M MES
0.2M NH4Cl, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.31 Å
R-free 0.234
|